Oh JK et al (2015) Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden. Int J Cancer 137(8):1979–1989

CAS  PubMed  Google Scholar 

Li G et al (2013) Coffee consumption and risk of colorectal cancer: a meta-analysis of observational studies. Public Health Nutr 16(2):346–357

CAS  PubMed  Google Scholar 

Cao S et al (2014) Coffee consumption and risk of prostate cancer: a meta-analysis of prospective cohort studies. Carcinogenesis 35(2):256–261

CAS  PubMed  Google Scholar 

Bravi F et al (2017) Coffee and the risk of hepatocellular carcinoma and chronic liver disease: a systematic review and meta-analysis of prospective studies. Eur J Cancer Prev 26(5):368–377

CAS  PubMed  Google Scholar 

Poole R et al (2017) Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ 359:j5024

PubMed  PubMed Central  Google Scholar 

Wang A et al (2016) Coffee and cancer risk: A meta-analysis of prospective observational studies. Sci Rep 6:33711

CAS  PubMed  PubMed Central  Google Scholar 

Bøhn SK, Blomhoff R, Paur I (2014) Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Mol Nutr Food Res 58(5):915–930

PubMed  Google Scholar 

Lee WJ, Zhu BT (2006) Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 27(2):269–277

CAS  PubMed  Google Scholar 

Pozner J et al (1986) Association of tumor differentiation with caffeine and coffee intake in women with breast cancer. Surgery 100(3):482–488

CAS  PubMed  Google Scholar 

Kotsopoulos J et al (2009) Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women. Cancer 115(12):2765–2774

CAS  PubMed  Google Scholar 

Cornelis MC, Coffee et al (2006) CYP1A2 genotype, and risk of myocardial infarction. JAMA 295(10):1135–1141

CAS  PubMed  Google Scholar 

Rivera-Oliver M, Díaz-Ríos M (2014) Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review. Life Sci 101(1–2):1–9

PubMed  PubMed Central  Google Scholar 

Gu L et al (1992) Biotransformation of caffeine, Paraxanthine, theobromine and Theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics 2(2):73–77

CAS  PubMed  Google Scholar 

Kalow W, Tang BK (1993) The use of caffeine for enzyme assays: a critical appraisal. Clin Pharmacol Ther 53(5):503–514

CAS  PubMed  Google Scholar 

Cornelis MC et al (2016) Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior. Hum Mol Genet 25(24):5472–5482

CAS  PubMed  Google Scholar 

van der Laan SW et al (2016) Cystatin C and cardiovascular disease: A Mendelian randomization study. J Am Coll Cardiol 68(9):934–945

PubMed  PubMed Central  Google Scholar 

Kurki MI et al (2023) FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613(7944):508–518

CAS  PubMed  PubMed Central  Google Scholar 

Deng Y et al (2022) Associations between potential causal factors and colorectal cancer risk: A systematic review and meta-analysis of Mendelian randomization studies. J Dig Dis 23(8–9):435–445

PubMed  Google Scholar 

Deng Y, Huang J, Wong MCS (2023) Associations of alcohol and coffee with colorectal cancer risk in East Asian populations: a Mendelian randomization study. Eur J Nutr 62(2):749–756

CAS  PubMed  Google Scholar 

Deng Y, Huang J, Wong MCS (2022) Associations between six dietary habits and risk of hepatocellular carcinoma: A Mendelian randomization study. Hepatol Commun 6(8):2147–2154

CAS  PubMed  PubMed Central  Google Scholar 

Larsson SC, Woolf B, Gill D (2023) Appraisal of the causal effect of plasma caffeine on adiposity, type 2 diabetes, and cardiovascular disease: two sample Mendelian randomisation study. BMJ Med 2(1):1–8

PubMed  PubMed Central  Google Scholar 

Larsson SC, Woolf B, Gill D (2022) Plasma Caffeine Levels and Risk of Alzheimer’s Disease and Parkinson’s Disease: Mendelian Randomization Study. Nutrients, 14(9)

Woolf B et al (2023) Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization. BMC Med 21(1):296

CAS  PubMed  PubMed Central  Google Scholar 

Slob EAW, Burgess S (2020) A comparison of robust Mendelian randomization methods using summary data. Genet Epidemiol 44(4):313–329

PubMed  PubMed Central  Google Scholar 

Teumer A (2018) Common methods for performing Mendelian randomization. Front Cardiovasc Med 5:51

PubMed  PubMed Central  Google Scholar 

Bowden J et al (2019) Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption. Int J Epidemiol 48(3):728–742

PubMed  Google Scholar 

Greco MF et al (2015) Detecting Pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat Med 34(21):2926–2940

Google Scholar 

Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect Estimation and bias detection through Egger regression. Int J Epidemiol 44(2):512–525

PubMed  PubMed Central  Google Scholar 

Verbanck M et al (2018) Detection of widespread horizontal Pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50(5):693–698

CAS  PubMed  PubMed Central  Google Scholar 

Wang Q et al (2025) Relationship of obesity, body fat, benign adrenal tumors and the mediating mechanism: a two-step mendelian randomization study. BMC Cancer 25(1):360

Grundy A et al (2022) Lifetime caffeine intake and the risk of epithelial ovarian cancer. Cancer Epidemiol 76:102058

PubMed  Google Scholar 

Arthur R, Kirsh VA, Rohan TE (2018) Associations of coffee, tea and caffeine intake with risk of breast, endometrial and ovarian cancer among Canadian women. Cancer Epidemiol 56:75–82

PubMed  Google Scholar 

Michels KB et al (2005) Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer. J Natl Cancer Inst 97(4):282–292

CAS  PubMed  Google Scholar 

Shafiei F et al (2019) Coffee and caffeine intake and risk of ovarian cancer: a systematic review and meta-analysis. Int J Gynecol Cancer 29(3):579–584

PubMed  Google Scholar 

Wang Y et al (2011) Coffee consumption and the risk of heart failure in Finnish men and women. Heart 97(1):44–48

PubMed  Google Scholar 

Carter P et al (2022) Coffee consumption and cancer risk: a Mendelian randomisation study. Clin Nutr 41(10):2113–2123

CAS  PubMed  PubMed Central  Google Scholar 

Baker JA et al (2005) Associations between black tea and coffee consumption and risk of lung cancer among current and former smokers. Nutr Cancer 52(1):15–21

PubMed  Google Scholar 

B’Chir F et al (2009) CYP1A2 genetic polymorphisms and adenocarcinoma lung cancer risk in the Tunisian population. Life Sci 84(21–22):779–784

PubMed  Google Scholar 

Sachse C et al (2003) Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism. Br J Clin Pharmacol 55(1):68–76

CAS  PubMed  PubMed Central  Google Scholar 

Gregg JR, Intake C et al (2023) Caffeine metabolism genotype, and survival among men with prostate cancer. Eur Urol Oncol 6(3):282–288

PubMed  Google Scholar 

Peng Y et al (2023) AhR promotes the development of Non-small cell lung cancer by inducing SLC7A11-dependent antioxidant function. J Cancer 14(5):821–834

CAS  PubMed  PubMed Central  Google Scholar 

Elson DJ, Kolluri SK (2023) Tumor-Suppressive functions of the Aryl hydrocarbon receptor (AhR) and AhR as a therapeutic target in cancer. Biology (Basel), 12(4)

Stensvold I, Jacobsen BK (1994) Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 5(5):401–408

CAS